Literature DB >> 9832088

Intimal hyperplasia thickness at follow-up is independent of stent size: a serial intravascular ultrasound study.

R Hoffmann1, G S Mintz, A D Pichard, K M Kent, L F Satler, M B Leon.   

Abstract

The purpose of this study was to determine whether the thickness of the intimal hyperplasia (IH) layer that accumulates within Palmaz-Schatz stents is dependent on stent size. Intravascular ultrasound (IVUS) and quantitative angiographic (QCA) studies were performed after stent implantation and at follow-up (5.4 +/- 3.8 months) in 161 patients with 177 lesions treated with 221 Palmaz-Schatz stents. Stent and lumen cross-sectional area (CSA) were measured. IH CSA and thickness at follow-up were calculated and compared with stent CSA and circumference. Maximum IH CSA and thickness were measured at the smallest follow-up lumen CSA; mean IH CSA and thickness was averaged over the length of the stent. Maximum IH CSA measured 4.8 +/- 2.4 mm2, and mean IH CSA measured 2.8 +/- 2.2 mm2. Maximum IH thickness (at the smallest follow-up lumen CSA) measured 0.60 +/- 0.36 mm, and mean IH thickness (over the length of the stent) measured 0.30 +/- 0.19 mm. There was a weak, but significant correlation between mean and maximum IH CSA versus stent CSA (r = 0.215, p <0.0001 and r = 0.355, p <0.0001, respectively). However, there was no correlation between mean or maximum IH thickness versus stent CSA (r = 0.018, p = 0.643 and r = 0.056, p = 0.463, respectively) or stent circumference (r = 0.002, p = 0.956 and r = 0.069, p = 0.361, respectively). IH thickness was found to be independent of the stent size. This explains the known higher frequency of restenosis in smaller stents compared with larger stents.

Entities:  

Mesh:

Year:  1998        PMID: 9832088     DOI: 10.1016/s0002-9149(98)00603-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

Review 2.  New imaging techniques for diagnosing coronary artery disease.

Authors:  Esteban Escolar; Guy Weigold; Anthon Fuisz; Neil J Weissman
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

3.  Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study.

Authors:  F Schiele; M K Batur; M F Seronde; N Meneveau; P Sewoke; A Bassignot; G Couetdic; F Caulfield; J P Bassand
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

4.  Drug-Coated Balloon-Only Angioplasty Outcomes in Diabetic and Nondiabetic Patients with De Novo Small Coronary Vessels Disease.

Authors:  Botey Katamu Benjamin; Wenjie Lu; Zhanying Han; Liang Pan; Xi Wang; Xiaofei Qin; Guoju Sun; Xule Wang; Yingguang Shan; Ran Li; Xiaolin Zheng; Wencai Zhang; Qiangwei Shi; Shuai Zhou; Sen Guo; Peng Qin; Chhatra Pratap Singh; Jianzeng Dong; Chunguang Qiu
Journal:  J Interv Cardiol       Date:  2021-12-01       Impact factor: 2.279

5.  Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectiveness.

Authors:  Flavio Roberto Azevedo de Oliveira; Luiz Alberto Piva E Mattos; Alexandre Abizaid; Andrea S Abizaid; J Ribamar Costa; Ricardo Costa; Rodolfo Staico; Roberto Botelho; J Eduardo Sousa; Amanda Sousa
Journal:  Arq Bras Cardiol       Date:  2013-10-08       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.